Expansion of inflammatory innate lymphoid cells in patients with common variable immune deficiency.

[1]  G. Sireci,et al.  Type 3 innate lymphoid cells producing IL-17 and IL-22 are expanded in the gut, in the peripheral blood, synovial fluid and bone marrow of patients with ankylosing spondylitis , 2015, Annals of the rheumatic diseases.

[2]  H. Einsele,et al.  Multicenter experience in hematopoietic stem cell transplantation for serious complications of common variable immunodeficiency. , 2015, The Journal of allergy and clinical immunology.

[3]  H. Spits,et al.  The biology of innate lymphoid cells , 2015, Nature.

[4]  G. Eberl,et al.  Development and regulation of RORγt+ innate lymphoid cells , 2014, FEBS letters.

[5]  J. Casanova,et al.  Corrigendum: Primary Immunodeficiency Diseases: An Update on the Classification from the International Union of Immunological Societies Expert Committee for Primary Immunodeficiency , 2014, Front. Immunol..

[6]  G. Pantaleo,et al.  Exhaustion of bacteria-specific CD4 T cells and microbial translocation in common variable immunodeficiency disorders , 2014, The Journal of experimental medicine.

[7]  Hergen Spits,et al.  Innate lymphoid cells in inflammation and immunity. , 2014, Immunity.

[8]  A. T. Te Velde,et al.  Composition of innate lymphoid cell subsets in the human skin: enrichment of NCR(+) ILC3 in lesional skin and blood of psoriasis patients. , 2014, The Journal of investigative dermatology.

[9]  H. Spits,et al.  Human innate lymphoid cells. , 2014, Blood.

[10]  É. Oksenhendler,et al.  Clinical picture and treatment of 2212 patients with common variable immunodeficiency. , 2014, The Journal of allergy and clinical immunology.

[11]  N. Rezaei,et al.  Cytokines in Common Variable Immunodeficiency as Signs of Immune Dysregulation and Potential Therapeutic Targets – A Review of the Current Knowledge , 2014, Journal of Clinical Immunology.

[12]  J. Casanova,et al.  Primary Immunodeficiency Diseases: An Update on the Classification from the International Union of Immunological Societies Expert Committee for Primary Immunodeficiency , 2014, Front. Immunol..

[13]  Henrique Veiga-Fernandes,et al.  Differentiation of Type 1 ILCs from a Common Progenitor to All Helper-like Innate Lymphoid Cell Lineages , 2014, Cell.

[14]  R. Sherkat,et al.  Evaluation of the T helper 17 cell specific genes and the innate lymphoid cells counts in the peripheral blood of patients with the common variable immunodeficiency , 2014, Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences.

[15]  S. Serrano,et al.  Innate lymphoid cells integrate stromal and immune signals to enhance antibody production by splenic marginal zone B cells , 2014, Nature Immunology.

[16]  Michael G. Constantinides,et al.  A committed hemopoietic precursor to innate lymphoid cells , 2014, Nature.

[17]  G. Ogg,et al.  A role for IL-25 and IL-33–driven type-2 innate lymphoid cells in atopic dermatitis , 2013, The Journal of experimental medicine.

[18]  F. Villanova,et al.  Characterization of innate lymphoid cells (ILC) in human skin and blood demonstrates increase of NKp44+ ILC3 in psoriasis , 2013, The Journal of investigative dermatology.

[19]  V. Pascual,et al.  Interferon Signature in the Blood in Inflammatory Common Variable Immune Deficiency , 2013, PloS one.

[20]  Jian-ping He,et al.  Nodular Regenerative Hyperplasia in Common Variable Immunodeficiency , 2013, Journal of Clinical Immunology.

[21]  C. Buskens,et al.  Human type 1 innate lymphoid cells accumulate in inflamed mucosal tissues , 2013, Nature Immunology.

[22]  R. Locksley,et al.  Innate lymphoid cells — a proposal for uniform nomenclature , 2013, Nature Reviews Immunology.

[23]  B. Bielekova,et al.  Inhibition of LTi Cell Development by CD25 Blockade Is Associated with Decreased Intrathecal Inflammation in Multiple Sclerosis , 2012, Science Translational Medicine.

[24]  H. Spits,et al.  Transcriptional control of innate lymphoid cells , 2012, European journal of immunology.

[25]  Klaus Warnatz,et al.  Pathogenesis of autoimmunity in common variable immunodeficiency , 2012, Front. Immun..

[26]  C. Cunningham-Rundles,et al.  Morbidity and mortality in common variable immune deficiency over 4 decades. , 2012, Blood.

[27]  C. Garlanda,et al.  AHR drives the development of gut ILC22 cells and postnatal lymphoid tissues via pathways dependent on and independent of Notch , 2011, Nature Immunology.

[28]  C. Cunningham-Rundles,et al.  Efficacy and safety of rituximab in common variable immunodeficiency‐associated immune cytopenias: a retrospective multicentre study on 33 patients , 2011, British journal of haematology.

[29]  M. Werner,et al.  T and B lymphocyte abnormalities in bone marrow biopsies of common variable immunodeficiency. , 2011, Blood.

[30]  S. Travis,et al.  IL-23–responsive innate lymphoid cells are increased in inflammatory bowel disease , 2011, The Journal of experimental medicine.

[31]  J. Glessner,et al.  Genome-wide association identifies diverse causes of common variable immunodeficiency. , 2011, The Journal of allergy and clinical immunology.

[32]  Erin F. Simonds,et al.  Single-Cell Mass Cytometry of Differential Immune and Drug Responses Across a Human Hematopoietic Continuum , 2011, Science.

[33]  G. Eberl,et al.  RORγt+ innate lymphoid cells regulate intestinal homeostasis by integrating negative signals from the symbiotic microbiota , 2011, Nature Immunology.

[34]  C. Cunningham-Rundles.  How I treat common variable immune deficiency. , 2010, Blood.

[35]  M. Colonna,et al.  Expansion of human NK-22 cells with IL-7, IL-2, and IL-1β reveals intrinsic functional plasticity , 2010, Proceedings of the National Academy of Sciences.

[36]  F. Powrie,et al.  Innate lymphoid cells drive IL-23 dependent innate intestinal pathology , 2010, Nature.

[37]  C. Loddenkemper,et al.  CCR6 is expressed on an IL-10–producing, autoreactive memory T cell population with context-dependent regulatory function , 2010, The Journal of experimental medicine.

[38]  H. Spits,et al.  Human NKp44+IL-22+ cells and LTi-like cells constitute a stable RORC+ lineage distinct from conventional natural killer cells , 2010, The Journal of experimental medicine.

[39]  L. Mayer,et al.  Pathogenesis and treatment of gastrointestinal disease in antibody deficiency syndromes. , 2009, The Journal of allergy and clinical immunology.

[40]  J. Lennerz,et al.  A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity , 2009, Nature.

[41]  B. Mora,et al.  Unravelling the Complexity of T Cell Abnormalities in Common Variable Immunodeficiency1 , 2007, The Journal of Immunology.

[42]  A. Plebani,et al.  Long-Term Follow-Up and Outcome of a Large Cohort of Patients with Common Variable Immunodeficiency , 2007, Journal of Clinical Immunology.

[43]  P. Mannon,et al.  Excess IL-12 but not IL-23 accompanies the inflammatory bowel disease associated with common variable immunodeficiency. , 2006, Gastroenterology.

[44]  M. Koss,et al.  Nodular lymphoid hyperplasia of the lung: a clinicopathologic study of 14 cases. , 2000, The American journal of surgical pathology.

[45]  L. Goodman,et al.  Use of Combination Chemotherapy for Treatment of Granulomatous and Lymphocytic Interstitial Lung Disease (GLILD) in Patients with Common Variable Immunodeficiency (CVID) , 2012, Journal of Clinical Immunology.

[46]  É. Oksenhendler,et al.  Granulomatous Disease in CVID: Retrospective Analysis of Clinical Characteristics and Treatment Efficacy in a Cohort of 59 Patients , 2012, Journal of Clinical Immunology.

[47]  Eren,et al.  The EUROclass trial: defining subgroups in common variable immunodeficiency. , 2008, Blood.

[48]  James J. Campbell,et al.  Expression of the chemokine receptors CCR4, CCR5, and CXCR3 by human tissue-infiltrating lymphocytes. , 2002, The American journal of pathology.